Recordati Makes Good Start to 2022 As Cold & Flu Sales Rebound
Executive Summary
Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.